| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 1. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | moxifloxacin (Avelox®) |
| Formulation | 400 mg film-coated tablet |
| Reference number | 209 |
| Indication | Treatment of bacterial infections in patients of 18 years and older caused by bacteria susceptible to moxifloxacin |
| Company | Bayer Healthcare Pharmaceuticals |
| BNF chapter | Infections |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 18/08/2003 |